Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Kidney cancer is a malignant tumor arising from renal parenchymal cells, with the most common type being clear cell renal carcinoma. It is more common in people over 50 years old, with slightly higher incidence in men than in women. Because the kidneys are located deep in the abdominal cavity, early tumors often have no symptoms and are easily overlooked, and are often diagnosed at middle or late stages. With advances in medical technology, more kidney cancer cases are being detected early during physical examinations, and treatment methods are also improving, especially in minimally invasive surgery and immunotherapy, bringing hope to patients.
The incidence of kidney cancer is higher in European and American countries, especially the United States, Germany, and Norway. In recent years, cases have also been increasing in Asian countries such as China, Japan, and Malaysia. Lifestyle changes, obesity, and smoking are considered the main reasons for the increase in incidence.
1. Tumor growth affecting kidney function
Kidney cancer often has no obvious symptoms in the early stage, but as the tumor grows, it compresses kidney tissue, causing renal function damage. Some patients present with back pain, hematuria, or an abdominal mass, which, if untreated, may lead to renal failure.
2. Prone to venous invasion and metastasis
Kidney cancer has a strong ability for vascular invasion, often spreading along the renal vein into the inferior vena cava, and even involving the atrium. In addition, metastasis to the lungs, bones, and brain is common, which is an important cause of poor prognosis.
3. Risk of local rupture and bleeding
Some kidney cancer patients may experience spontaneous tumor rupture, leading to intra-abdominal bleeding and even hemorrhagic shock. This acute complication requires timely rescue.
4. Compression of surrounding organs
As the tumor grows, it may compress the gastrointestinal tract, spine, or nerves, causing corresponding symptoms and further affecting patient quality of life and treatment timing.
This treatment involves isolating immune cells from the patient or a healthy donor, expanding and activating them before reinfusion into the body to enhance their ability to recognize and attack cancer cells. It is suitable for postoperative adjuvant therapy or for patients who cannot undergo surgery, with the advantages of fewer side effects and personalized precision. United Life International Medical Center has widely applied this technology in kidney cancer immune management, helping reduce recurrence and prolong survival.
During actual treatment, patients undergoing surgery, radiotherapy, and chemotherapy often face impaired immune function, increased infection risk, and slow recovery. To better support the treatment process, improve tolerance, and enhance survival quality, it is necessary to scientifically design phased immune reconstruction plans across different treatment cycles.
● Short-term Plan: Rapidly enhance immunity through immune cell reinfusion to boost the effectiveness of anti-cancer treatment.
● Mid-term Plan: Reduce side effects of traditional treatments, promote physical recovery, and complete standardized treatment courses.
● Long-term Plan: Improve overall immunity through immune cell reconstruction, gut immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, thereby enhancing quality of life and prolonging survival.
1. Minimally invasive partial nephrectomy
For early localized kidney cancer, laparoscopic or robot-assisted partial nephrectomy preserves more kidney tissue, maximizing renal function. This type of surgery involves minimal trauma, quick recovery, and short hospital stays, making it one of the mainstream treatment options today.
2. Radical nephrectomy
When the tumor is large or in a special location that makes partial resection difficult, radical nephrectomy remains one of the standard options. It can be performed via open or laparoscopic surgery, and postoperative drug therapy provides better control.
3. Targeted drug therapy
Targeted therapies such as tyrosine kinase inhibitors and VEGF inhibitors have become important treatment options for metastatic kidney cancer. These drugs inhibit tumor angiogenesis and cell proliferation, delaying disease progression, and are often used as adjuvant or standalone treatments.
4. Radiotherapy and palliative care
Although kidney cancer is less sensitive to radiotherapy, in specific cases such as bone or brain metastases, radiotherapy can effectively relieve pain and prolong survival. Palliative care helps improve quality of life in advanced patients.
Once kidney cancer is diagnosed, systematic and standardized treatment management is required. Due to its high metastatic potential and complexity, experts at United Life International Medical Center emphasize that early intervention, scientific diagnosis and treatment, and multidisciplinary collaboration are key to improving cure rates. Comprehensive treatment models including immune cell therapy have become an important direction for future development.
